Filter Results:
(3)
Show Results For
- All HBS Web
(3)
- Research (3)
- Faculty Publications (1)
Show Results For
- All HBS Web
(3)
- Research (3)
- Faculty Publications (1)
Page 1 of 3
Results
- February 2019 (Revised September 2019)
- Case
Theranos: The Unicorn That Wasn't
By: Joseph B. Fuller and John Masko
In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains... View Details
Keywords: Theranos; Blood; Lab Testing; Fraud; Holmes; Balwani; Shultz; Carreyrou; Securities And Exchange Commission; Food And Drug Administration; FDA; SEC; Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Medical Devices and Supplies Industry
Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
- 27 Jan 2023
- Op-Ed
Have We Lost Sight of Integrity?
federal indictment. Tesla’s Elon Musk is facing trial for deceptively driving up the price of Tesla stock by falsely claiming to have the “funding secured” to take his company private. Theranos under Elizabeth Holmes and Sunny Balwani... View Details
Keywords: by Bill George
- 17 Sep 2021
- Research & Ideas
The Trial of Elizabeth Holmes: Visionary, Criminal, or Both?
Ramesh Balwani, had long known that Theranos’ home blood test didn’t work, but misled investors to keep money flowing in. Holmes and Balwani are accused of defrauding patients, doctors, and investors of over $700 million. At its peak in... View Details